Archives

by in
Entry Author Date Location
Stromedix Chief, After Reloading the Company Treasury, Sets Sight on Trial for Deadly Lung Disease 02/07/11 Boston
Clinical Data Stock Surging on FDA Approval of Anti-Depression Drug 01/24/11 Boston
Plexxikon, Roche Drug Extends Lives in Patients With Deadly Skin Cancer 01/19/11 San Francisco
Ariad Pharma Stock Up More than 25 Percent on Positive Phase III Data 01/18/11 Boston
Allon Starts Trial for Brain Disease 01/06/11 Seattle
Syndax Pharma Study Offers Clues that Lung Cancer Treatment Could Benefit Subset of Patients 12/10/10 Boston
Seattle Genetics, Millennium’s Encore: Souped-Up Antibody Looks Better in 2nd Trial 12/07/10 Seattle
Glaxo Ends Resveratrol Drug Study 12/01/10 Boston
Pearl Therapeutics, Fresh Off Big VC Round, Tops $3B Lung Drug in Head-to-Head Trial 12/01/10 San Francisco
Sangart Looks to Fund More Human Trials of its Oxygen-Carrying Blood Adjunct 11/17/10 San Diego
Anthera, On a Lean Budget, Seeks to Tap Big Heart Attack Market By Blocking Inflammation 11/16/10 San Francisco
Ambit Files for IPO, Arena Pharmaceuticals Says Weight-Loss Drug on Track, ESRI Launches Medical Place History Map App, & More San Diego Life Sciences News 11/12/10 San Diego
Optimer Halts Study After Antibiotic for Traveler’s Diarrhea Linked to Rash; Shares Drop 11/10/10 San Diego
Dana-Farber and Bay-Area Startup File Responses in Lawsuit Over Rights to Cancer Molecule 11/10/10 Boston
Hyperion Hits Goal in Trial for Rare-Disease Drug, Prepping FDA Application 11/03/10 San Francisco
Ironwood Passes 4th Big Trial 11/01/10 Boston
Antigenics Expands Experimental Cancer Treatment, Novartis Adds to Cambridge Presence, Boston Scientific Sells Unit to Stryker, & More Boston-Area Life Sciences News 10/29/10 Boston
Triangulation: How Universities, Government, and Business Can Stir More Innovation 10/28/10 San Francisco
Omeros Nabs $25M from Paul Allen and the State, Immune Design Strikes 1st Big Deal, & More Seattle-Area Life Sciences News 10/28/10 Seattle
Resolvyx and Celtic Ink Dry Eye Deal 10/26/10 Boston
Genzyme Cancer Treatment Doubles Remission Rate 10/20/10 Boston
Calistoga Starts Mid-Stage Trial 10/19/10 Seattle
Genentech’s Souped-Up Breast Cancer Drug Beats Original Herceptin in Head-to-Head Study 10/08/10 San Francisco
VentiRx Cancer Drug Passes Early Trial 10/04/10 San Diego
ZymoGenetics Melanoma Drug Shows Survival Data, Adding More Juice to Bristol’s Pipeline 09/29/10 Seattle
ProNAi Therapeutics Advances Gene-Silencing Cancer Drug, Marina Biotech Provides Delivery Package 09/28/10 Detroit
Seattle Genetics, Millennium Generate “Dream” Data With Empowered Antibody Drug for Cancer 09/27/10 Seattle
Rigel Arthritis Drug Passes Trial 09/23/10 San Francisco
Biogen Rival Reaches Finish Line with Oral Drug for MS 09/22/10 Boston
Zalicus, Formerly the Bicoastal Biotech CombinatoRx, Seeks New Identity with Name Fit for a Warrior 09/20/10 Boston
Page 2 of 8 « previous page · next page »
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.